台股 » 個股 » 高端疫苗 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

高端疫苗

(6547)
可現股當沖
  • 股價
    48.00
  • 漲跌
    ▲1.65
  • 漲幅
    +3.56%
  • 成交量
    7,468
  • 產業
    上櫃 生技醫療類股
  • 712人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
高端疫苗 (6547)籌碼相關-華南永昌-忠孝 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

華南永昌-忠孝 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2026/07/0200.00545.4545.40-52,407-0.21%
2026/07/0100.001045.4545.30-102,423-0.41%
2026/06/301545.8200.0045.45152,4330.62%
2026/06/2900.001646.8847.20-162,412-0.66%
2026/06/24445.5600.0046.1042,4890.16%
2026/06/231246.1300.0045.40122,5780.47%
2026/06/0300.001544.5045.35-153,660-0.41%
2026/06/01545.8500.0046.0053,6400.14%
2026/05/291045.1600.0045.20103,6480.27%
2026/05/18149.15149.0048.8003,5120.00%
2026/04/27048.4500.0048.5003,8240.00%
2026/04/0100.00058.7058.7003,1620.00%
2026/03/2600.001.152.4652.00-1.13,039-0.03%
2026/03/2500.00458.5056.50-42,939-0.14%
2026/03/24456.20659.3357.50-22,864-0.07%
2026/03/2300.00352.0754.50-31,936-0.15%
2026/03/19145.1000.0045.1011,6460.06%
2026/03/18241.0000.0041.0021,6440.12%
2026/01/3000.000.237.9537.55-0.22,036-0.01%
2026/01/290.238.1500.0038.100.21,9940.01%
2026/01/2800.001942.2741.50-191,898-1.00%
2026/01/20937.5700.0037.0591,6030.56%
2026/01/191037.6100.0037.45101,6160.62%
2025/12/1600.00137.9037.70-11,540-0.06%
2025/12/0300.000.240.6540.10-0.21,505-0.01%
2025/11/270.140.9500.0040.700.11,4350.01%
2025/11/260.140.4000.0040.300.11,4190.01%
2025/11/2500.000.139.0538.20-0.11,3810.00%
2025/11/240.139.8500.0039.650.11,3600.00%
2025/11/1400.00737.8537.40-71,119-0.63%
2025/11/11036.2500.0036.3001,0380.00%
2025/11/10236.9000.0036.8521,0260.19%
2025/11/04134.7500.0034.3019320.11%
2025/10/28136.2000.0035.8519300.11%
2025/10/23437.9600.0037.4049130.44%
2025/10/22038.20538.4538.15-5900-0.55%
2025/10/20536.5900.0036.8058690.57%
2025/10/13037.10637.1037.35-6884-0.68%
2025/09/040.139.3000.0039.300.19980.01%
2025/07/2800.00042.4542.5502,0820.00%
2025/07/21042.0000.0042.2002,3800.00%
高端疫苗總經理李思賢:今年是飛黃騰達的一年 鎖定腸病毒71型疫苗東協市場Anue鉅亨-2026/03/03
高端疫苗 相關文章